A Model to Identify Specific Predictors of Spatial Neglect Recovery
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study examines methods to better predict improvement of a hidden disability of functional vision, spatial neglect, following stroke. Spatial neglect is a tendency to make visual judgment and movement errors mislocating the body and objects in space. The investigators are using specialized statistical methods to compute the proportion of improvement accounted for by personal characteristics of each stroke survivor, the proportion of improvement accounted for by the unique visual-spatial errors made by each subject, and the proportion of improvement accounted for by each treatment administered. The investigators will also examine whether brain imaging predicts how rapidly improvement occurs. Lastly, the study tests whether improvements that are meaningful to the survivor can be measured in a way that still allows detection of small and scientifically eloquent performance changes.
| Condition |
|---|
|
Spatial Neglect Hemispatial Neglect Hemineglects Unilateral Neglect / Patient Unilateral Inattention Sensory Neglect |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Comparing Prism Adaptation Therapy and Bromocriptine Medication for Spatial Neglect: Theoretical and Practical Outcomes |
- Comparing two treatments for hidden disabilities in functional vision after stroke. [ Time Frame: 6 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 80 |
| Study Start Date: | January 2009 |
| Estimated Study Completion Date: | October 2020 |
| Estimated Primary Completion Date: | January 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Prism adaptation therapy |
| Bromocriptine pharmacotherapy |
Detailed Description:
DESCRIPTION: Spatial neglect, pathologically asymmetric spatial behavior resulting from a brain injury (Heilman, 1979) and causing functional disability (Barrett and Burkholder, 2006) may occur in 20-50% of strokes, up to 350,000 Americans annually (Ringman et al., 2004; American Stroke Assoc., 2007). Difficulty eating, dressing, and navigating in complex environments occurs acutely in this disorder, but even if symptoms improve in chronic recovery, people with spatial neglect are more likely to lose functional independence (Katz et al., 1999). Current standard clinical approaches are not theory driven, and widely-employed therapies may be only marginally effective. In this proposal, we suggest two means by which scientific acute spatial neglect treatment can be implemented. In available studies, subject heterogeneity may have obscured treatment effects. Across methods, studies used single subject, case series, and group analytic designs, but did not attempt to reconcile the distinct advantages offered by individual versus group analytic approaches. Different treatments might affect different spatial cognitive recovery functions, but simple, global outcome measures may not reflect these changes. Modeling both subject-specific and group effects is also an extremely useful method of examining targeted treatment effects. We will collect spatial neglect treatment response data over four years, for two promising and feasible spatial neglect treatments: prism adaptation training and dopaminergic medication. With mechanism-specific outcome assessment and hierarchical linear modeling, we will examine whether treatments result in predictable response. We will also examine whether controlling for subject-specific predictors models group recovery trajectory. Lastly, we will examine current standard global outcome measures instruments which have not been fully psychometrically developed, and attempt to predict subject- and group-specific recovery profiles for these variables. We hope this research will improve our ability to design cognitive rehabilitation treatment studies. It may also, however, improve our ability to translate cognitive neuroscience models of action, spatial knowledge, and attention, to treatments to optimize adaptive movement in complex environments. PUBLIC HEALTH RELEVANCE: This study investigates novel methods of outcome analysis for comparing two treatments for hidden disabilities in functional vision after stroke. We hope this research will improve our ability to design cognitive rehabilitation treatment studies. It may also, however, improve our ability to bring basic brain science to the bedside, to optimize stroke survivors' adaptive movement and balanced visual-spatial function in complex environments.
Although subjects are assigned to treatments in this study, we classified the study as observational because there are no quasi-experimental options fitting its hierarchical design under the interventional study description. At no point do we examine the independent effect of treatments; rather, we assign subjects to treatments in order to learn if treatment exerts an additional effect IN COMBINATION WITH 1) individual differences and 2) performance characterization of spatial bias type immediately after stroke. We are lastly making separate examination of the predictive effect of brain lesion location in combination with variables 1) and 2). NO traditional efficacy comparisons between the two treatments to which subjects are assigned, are made. Neither treatment is considered "control" or "placebo," and there is no attempt to match severity or other relevant variables between the two treatment assignments.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Stroke survivors with right brain stroke and evidence of a hidden disability of functional vision (spatial neglect)
Inclusion Criteria:
- Stroke survivors with right brain stroke and evidence of a hidden disability of functional vision (spatial neglect)
- Can give consent
Exclusion Criteria:
- Other neurological conditions
Contacts and Locations| United States, New Jersey | |
| Kessler Institute of Rehabilitation | |
| Chester, New Jersey, United States, 07930 | |
| Kessler Institute of Rehabilitation | |
| Saddle Brook, New Jersey, United States, 07663 | |
| Kessler Foundation Research Center | |
| West Orange, New Jersey, United States, 07052 | |
| Principal Investigator: | A M Barrett, MD | Kessler Foundation |
More Information
Additional Information:
No publications provided
| Responsible Party: | A. M. Barrett, MD, Director, Stroke Research, Kessler Foundation |
| ClinicalTrials.gov Identifier: | NCT00990353 History of Changes |
| Other Study ID Numbers: | D-624-08, 1R01NS055808-01A2 |
| Study First Received: | July 27, 2009 |
| Last Updated: | May 11, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Kessler Foundation:
|
Spatial neglect hemineglect stroke cognition |
prism adaptation Hierarchical linear modeling growth curve modeling |
Additional relevant MeSH terms:
|
Perceptual Disorders Neurobehavioral Manifestations Neurologic Manifestations Nervous System Diseases Signs and Symptoms Bromocriptine Antiparkinson Agents Anti-Dyskinesia Agents Central Nervous System Agents |
Therapeutic Uses Pharmacologic Actions Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs Dopamine Agonists Dopamine Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action |
ClinicalTrials.gov processed this record on May 19, 2013